Pharmacokinetic studies showed excellent brain uptake and rapid clearance in mice, with no lipophilic metabolites and higher binding to tau over Aβ [59].[60] In-vitro studies of this ligand demonstrated binding to NFTs in AD brain sections and a higher affinity for tau fibrils than Aβ fibrils [61]. Here, MAPT is linked to Alzheimer disease.